| Name | Walgreens #3388 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 225 N Hall Rd, Alcoa, Tennessee 37701 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (865) 982-2463 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The Lymphoma Research Foundation (LRF), the nation's largest non-profit organization devoted to lymphoma research, is partnering with John Theurer Cancer Center, one of the nation's 50 best hospitals for cancer, to bring the lymphoma community information about the rapidly changing world of lymphoma treatment.
Cylene Pharmaceuticals, Inc. announced today the initiation of a Phase I clinical trial of their first-in-class, oral CK2 inhibitor CX-4945 in patients with multiple myeloma. Cylene also announced the simultaneous closing of a $12 million financing with participation from existing investors including Sanderling Ventures, HBM BioVentures (Cayman) Ltd., Novartis BioVenture Fund, BioVentures Investors, Lilly Ventures, Mitsui & Co. and Morningside Venture Investments Ltd.
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase III VELOUR trial evaluating the investigational agent ZALTRAP, also known as VEGF Trap, in combination with the FOLFIRI chemotherapy regimen versus a regimen of FOLFIRI plus placebo met its primary endpoint of improving overall survival in the second-line treatment of metastatic colorectal cancer.
Premenopausal women who were heavier than average at birth or had not been breastfed as infants appear to be at increased risk for developing breast cancer, epidemiologists at the University at Buffalo's School of Public health and Health Professions have found.
› Verified 7 days ago
| NPI Number | 1033124045 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #03388 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 225 N Hall Rd, Alcoa, TN 37701 |
| Phone Number | 865-982-2463 |
News Archive
The Lymphoma Research Foundation (LRF), the nation's largest non-profit organization devoted to lymphoma research, is partnering with John Theurer Cancer Center, one of the nation's 50 best hospitals for cancer, to bring the lymphoma community information about the rapidly changing world of lymphoma treatment.
Cylene Pharmaceuticals, Inc. announced today the initiation of a Phase I clinical trial of their first-in-class, oral CK2 inhibitor CX-4945 in patients with multiple myeloma. Cylene also announced the simultaneous closing of a $12 million financing with participation from existing investors including Sanderling Ventures, HBM BioVentures (Cayman) Ltd., Novartis BioVenture Fund, BioVentures Investors, Lilly Ventures, Mitsui & Co. and Morningside Venture Investments Ltd.
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase III VELOUR trial evaluating the investigational agent ZALTRAP, also known as VEGF Trap, in combination with the FOLFIRI chemotherapy regimen versus a regimen of FOLFIRI plus placebo met its primary endpoint of improving overall survival in the second-line treatment of metastatic colorectal cancer.
Premenopausal women who were heavier than average at birth or had not been breastfed as infants appear to be at increased risk for developing breast cancer, epidemiologists at the University at Buffalo's School of Public health and Health Professions have found.
› Verified 7 days ago
News Archive
The Lymphoma Research Foundation (LRF), the nation's largest non-profit organization devoted to lymphoma research, is partnering with John Theurer Cancer Center, one of the nation's 50 best hospitals for cancer, to bring the lymphoma community information about the rapidly changing world of lymphoma treatment.
Cylene Pharmaceuticals, Inc. announced today the initiation of a Phase I clinical trial of their first-in-class, oral CK2 inhibitor CX-4945 in patients with multiple myeloma. Cylene also announced the simultaneous closing of a $12 million financing with participation from existing investors including Sanderling Ventures, HBM BioVentures (Cayman) Ltd., Novartis BioVenture Fund, BioVentures Investors, Lilly Ventures, Mitsui & Co. and Morningside Venture Investments Ltd.
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase III VELOUR trial evaluating the investigational agent ZALTRAP, also known as VEGF Trap, in combination with the FOLFIRI chemotherapy regimen versus a regimen of FOLFIRI plus placebo met its primary endpoint of improving overall survival in the second-line treatment of metastatic colorectal cancer.
Premenopausal women who were heavier than average at birth or had not been breastfed as infants appear to be at increased risk for developing breast cancer, epidemiologists at the University at Buffalo's School of Public health and Health Professions have found.
› Verified 7 days ago
Cvs Pharmacy #06359 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 111 S Hall Rd, Alcoa, Tennessee 37701 Phone: (865) 985-4780 | |
Walgreens #3388 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 225 N Hall Rd, Alcoa, Tennessee 37701 Phone: (865) 982-2463 | |
Wal-mart Pharmacy 10-0672 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1030 Hunters Xing, Alcoa, Tennessee 37701 Phone: (865) 984-2671 | |
Kroger Pharmacy #862 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 244 South Halls Road, Alcoa, Tennessee 37701 Phone: (865) 977-7441 | |
Blount Discount Pharmacy Inc Type: Pharmacy Location: 129 Gill St, Alcoa, Tennessee 37701 Phone: (865) 984-7704 |